Live feed16:05:00·175dPRReleasevia QuantisnowAbivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative ColitisByQuantisnow·Wall Street's wire, on your screen.ABVX· Abivax SAHealth Care
